Azole Resistance Mechanisms in Pathogenic Malassezia furfur
Open Access
- 19 April 2021
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 65 (5)
- https://doi.org/10.1128/aac.01975-20
Abstract
Malassezia spp. are emerging fungal pathogens causing opportunistic skin and severe systemic infection. Nosocomial outbreaks are associated with azole resistance, and understanding of the underlying mechanisms is limited to knowledge of other fungal species. Here, we identified distinct antifungal susceptibility patterns in 26 Malassezia furfur isolates derived from healthy and diseased individuals. A Y67F CYP51 mutation was identified in five isolates of M. furfur. However, this mutation alone was insufficient to induce reductions in azole susceptibility in the wild-type strain. RNA sequencing (RNA-seq) and differential gene analysis of strains derived from individuals with healthy or disease backgrounds exposed to clotrimazole in vitro identified several key metabolic pathways and transporter proteins which are involved in reducing azole susceptibility. The pleiotropic drug transporter gene PDR10 was the single most highly upregulated transporter gene in multiple strains of M. furfur after azole treatment, and increased expression of PDR10 is associated with reduced azole susceptibility in some systemic-disease isolates of M. furfur. Deletion of PDR10 in a pathogenic M. furfur strain with reduced susceptibility reduced MICs to those of susceptible isolates. In light of the current dearth of antifungal technologies, globally emerging multiazole resistance, and broad use of azoles in agriculture and consumer care, an improved understanding of the mechanisms underlying intrinsic and acquired azole resistance in Malassezia is crucial for development of antibiotic stewardship and antifungal treatment strategies.Keywords
Funding Information
- IAF-PP (H1801a016)
This publication has 47 references indexed in Scilit:
- Functional expression and characterization of CYP51 from dandruff-causing Malassezia globosaFEMS Yeast Research, 2010
- Structural Characterization of CYP51 from Trypanosoma cruzi and Trypanosoma brucei Bound to the Antifungal Drugs Posaconazole and FluconazolePLoS Neglected Tropical Diseases, 2010
- Role of the Y134F mutation in cyp51 and overexpression of cyp51 in the sensitivity response of Puccinia triticina to epoxiconazoleCrop Protection, 2009
- Epidemiological trends in skin mycoses worldwideMycoses, 2008
- Resistance to Antifungal Agents: Mechanisms and Clinical ImpactClinical Infectious Diseases, 2008
- Candida albicans drug resistance – another way to cope with stressMicrobiology, 2007
- Genome-Wide Expression Profile Analysis Reveals Coordinately Regulated Genes Associated with Stepwise Acquisition of Azole Resistance in Candida albicans Clinical IsolatesAntimicrobial Agents and Chemotherapy, 2003
- Inducible Azole Resistance Associated with a Heterogeneous Phenotype in Candida albicansAntimicrobial Agents and Chemotherapy, 2001
- Does Long-Term Itraconazole Prophylaxis Result in In Vitro Azole Resistance in Mucosal Candida albicans Isolates from Persons with Advanced Human Immunodeficiency Virus Infection?Antimicrobial Agents and Chemotherapy, 2000
- An Epidemic ofMalassezia pachydermatisin an Intensive Care Nursery Associated with Colonization of Health Care Workers' Pet DogsThe New England Journal of Medicine, 1998